AVAILABLE SMALLPOX/MONKEYPOX TREATMENTS

$Chimerix(CMRX.US)$ : "TEMBEXA" SMALLPOX/MONKEYPOX ANTI-VIRAL. (FDA-APPROVED  2021;ALL AGES); Recently Announced On 5/16/22,$325 Million CASH Contract (To be paid by end of Q2 2022) With a 20% ROYALTY FEE ON ALL SALES OBTAINED BY $Emergent BioSolutions(EBS.US)$
$SIGA Technologies(SIGA.US)$ : "TPOXX" SMALLPOX ANTI-VIRAL(FFDA-APPROVED IN 2018)$7.5 MILLION DOLLAR ORDER ($3.5 IN 2022/ $4 MILLION IN 2023)
$Emergent BioSolutions(EBS.US)$ :SmallPox/MonkeyPox Vaccine. "There are more than 100 million doses of an older smallpox vaccine,ACAM2000,which has some significant side effects...previously produced by Sanofi,and is now made by Emergent BioSolutions" -REUTERS
$BAVN/BVNRY:"Jynneos" SmallPox Vaccine. CDC officials said there are more than 1,000 doses of the vaccine in the national stockpile. Approved in the United States in 2019, Jynneos, made by Bavarian Nordic,is approved in the U.S. for use against Smallpox and Monkeypox in high risk adults aged 18 & older
$Moderna(MRNA.US)$ : Company Has Begun SmallPox Vaccine Testing